Samsara BioCapital, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001744967

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q1 2024 · 39 positions · Total reported value $646.37M · Top-10 concentration 76.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 37.0% · 3 new · 7 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q1 2024 13F filing, Samsara BioCapital, LLC disclosed 39 equity positions with a combined reported value of $646.37M. The filing implies a focused portfolio: its ten largest positions account for 76.2% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2024 were SRRK ($120.57M), CRGX ($92.00M), MLYS ($65.52M). By sector, the heaviest allocations are Health Care 64.1%, Other 35.9%. Versus the prior quarter, allocation shifted toward Health Care (+20.3pp) and away from Other (-19.9pp).

Versus the prior quarter, Samsara BioCapital, LLC opened 3 new positions, trimmed 7 and fully exited 0, a turnover rate of 37.0% of positions. The portfolio's overlap with the prior quarter was 82% of names.

The largest new positions opened in Q1 2024 were LENZ ($26.99M), JSPR ($15.41M), ADVM ($4.12M).

Of the 5 positions fully exited versus the prior quarter, the largest were RYZB ($114.76M), GRPH ($22.16M), PEPG ($2.97M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • LENZ LENZ THERAPEUTICS INC · $26.99M
  • JSPR JASPER THERAPEUTICS INC · $15.41M
  • ADVM ADVERUM BIOTECHNOLOGIES INC · $4.12M

Fully Exited (vs previous quarter)

  • RYZB RAYZEBIO INC · prev qtr: $114.76M
  • GRPH GRAPHITE BIO INC · prev qtr: $22.16M
  • PEPG PEPGEN INC · prev qtr: $2.97M
  • RAIN RAIN ENHANCEMENT TECHNOLOGIE · prev qtr: $2.44M
  • SNCE SCIENCE 37 HOLDINGS INC · prev qtr: $240.30K

Insider Transactions (Form 4)

Latest Samsara BioCapital, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Samsara BioCapital, LLC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 27 positions worth $1.05B in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • SEC registration: 801-113741 (status: Approved), registered 2018-07-27
  • Regulatory AUM (Form ADV): $2.17B as of 2026-10-28
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds

Portfolio Structure

  • 27 positions · $1.05B reported value (Q3 2026)
  • Top 10 holdings = 87.9% of reported value
  • Largest position: SRRK (SCHOLAR ROCK HLDG CORP) at 31.7%
  • Average position size: $38.95M

Sector Tilt

  • Health Care 91.8%
  • Industrials 8.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 3 new, 3 added, 7 reduced
  • 14 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 64.1%
Other 35.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 6.79M $120.57M 18.65%
18.65%
Hold
2 4.12M $92.00M 14.23%
14.23%
Hold
3 5.07M $65.52M 10.14%
10.14%
Add
4 1.27M $64.53M 9.98%
9.98%
Hold
5 3.77M $40.73M 6.30%
6.30%
Add
6 453.64K $31.55M 4.88%
4.88%
Reduce
7 1.21M $26.99M 4.17%
4.17%
New
8 2.78M $17.29M 2.67%
2.67%
Hold
9 2.52M $17.03M 2.63%
2.63%
Hold
10 967.53K $16.34M 2.53%
2.53%
Hold
11 525.00K $15.41M 2.38%
2.38%
New
12 1.46M $15.35M 2.37%
2.37%
Hold
13 799.27K $13.29M 2.06%
2.06%
Hold
14 850.00K $12.15M 1.88%
1.88%
Hold
15 1.56M $11.97M 1.85%
1.85%
Hold
16 1.79M $9.56M 1.48%
1.48%
Hold
17 1.68M $9.47M 1.47%
1.47%
Hold
18 172.65K $7.48M 1.16%
1.16%
Hold
19 6.13M $7.23M 1.12%
1.12%
Hold
20 180.21K $6.78M 1.05%
1.05%
Reduce
21 3.64M $6.30M 0.97%
0.97%
Hold
22 347.50K $5.59M 0.86%
0.86%
Hold
23 630.00K $5.00M 0.77%
0.77%
Hold
24 206.78K $4.87M 0.75%
0.75%
Add
25 396.00K $4.16M 0.64%
0.64%
Hold
26 291.67K $4.12M 0.64%
0.64%
New
27 540.30K $3.78M 0.58%
0.58%
Add
28 196.43K $3.24M 0.50%
0.50%
Hold
29 669.30K $1.78M 0.28%
0.28%
Hold
30 154.66K $1.49M 0.23%
0.23%
Hold
31 1.05M $1.47M 0.23%
0.23%
Hold
32 202.35K $1.33M 0.20%
0.20%
Hold
33 696.17K $863.25K 0.13%
0.13%
Hold
34 689.71K $703.50K 0.11%
0.11%
Hold
35 172.09K $216.83K 0.03%
0.03%
Hold
36 78.13K $101.57K 0.02%
0.02%
Hold
37 82.34K $62.16K 0.01%
0.01%
Hold
38 133.33K $40.33K 0.01%
0.01%
Hold
39 100.00K $3.02K 0.00%
0.00%
Hold

FAQ

What did Samsara BioCapital, LLC buy in 2024-Q1?

In its 2024-Q1 13F filing, Samsara BioCapital, LLC reported 39 equity positions worth $646.37M in aggregate; its largest disclosed positions were SRRK ($120.57M), CRGX ($92.00M), MLYS ($65.52M).

How large is Samsara BioCapital, LLC's portfolio?

Samsara BioCapital, LLC reported $646.37M of long equity holdings across 39 positions as of 2024-Q1. Top-10 holdings account for 76.2% of reported value.

What is Samsara BioCapital, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/samsara-biocapital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →